Alan Auerbach
Chief Executive Officer at PUMA BIOTECHNOLOGY, INC.
Net worth: 44 M $ as of 2024-02-28
Profile
Alan H.
Auerbach founded Cougar Biotechnology, Inc. and Puma Biotechnology, Inc. He occupies the position of Chairman, President & Chief Executive Officer for Puma Biotechnology, Inc.
In his past career he occupied the position of Vice President of Seidler Cos., Inc., Chairman, President & Chief Executive Officer at Innovative Acquisitions Corp., President, Chief Executive Officer & Director at Cougar Biotechnology, Inc., Vice President & Senior Research Analyst at Diagnostic Products Corp.
and Vice President & Senior Research Analyst at Wells Fargo Securities (Old).
Alan H.
Auerbach received an undergraduate degree from Boston University and a graduate degree from the University of Southern California.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
14.92% | 2024-02-11 | 7,097,743 ( 14.92% ) | 44 M $ | 2024-02-28 |
Alan Auerbach active positions
Companies | Position | Start |
---|---|---|
PUMA BIOTECHNOLOGY, INC. | Chief Executive Officer | 2011-09-30 |
Former positions of Alan Auerbach
Companies | Position | End |
---|---|---|
RADIUS HEALTH, INC. | Director/Board Member | 2017-12-28 |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Chairman | 2011-12-08 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Founder | 2009-07-12 |
Wells Fargo Securities (Old) | Analyst-Equity | 2003-03-31 |
Seidler Cos., Inc. | Corporate Officer/Principal | 1998-04-30 |
Training of Alan Auerbach
Boston University | Undergraduate Degree |
University of Southern California | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PUMA BIOTECHNOLOGY, INC. | Health Technology |
Private companies | 6 |
---|---|
Diagnostic Products Corp.
Diagnostic Products Corp. Medical SpecialtiesHealth Technology Diagnostic Products Corp. provides immunodiagnostic systems, which includes IMMULITE series of immunoassay systems, more than 75 immunoassays. It also designs and manufactures automated laboratory instrumentation and automation solutions. Diagnostic Products is located in Los Angeles, CA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Finance |
Wells Fargo Securities (Old) | Finance |
Seidler Cos., Inc. | Finance |